EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
You are here
Document C:2002:101:TOC
Official Journal of the European Communities, C 101, 26 April 2002
Official Journal of the European Communities, C 101, 26 April 2002
Official Journal of the European Communities, C 101, 26 April 2002
Display all documents published in this Official Journal
Language
PDF
| Official Journal of the European Communities | ISSN
0378-6986 C 101 Volume 45 26 April 2002 |
| English edition | Information and Notices | ||
| Notice No | Contents | Page | |
| I Information | |||
| Commission | |||
| 2002/C 101/01 | Euro exchange rates | 1 | |
| 2002/C 101/02 | Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 March to 15 April 2002 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93) | 2 | |
| 2002/C 101/03 | Prior notification of a concentration (Case COMP/M.2815 — Sanmina-SCI/Hewlett-Packard) (1) | 8 | |
| EN | (1) Text with EEA relevance | ||